Please login to the form below
Almirall
This page shows the latest Almirall news and features for those working in and with pharma, biotech and healthcare.
Sun Pharma passes milestone with novel psoriasis drug approval
Last November, Sun Pharma’s European licensee for tildrakizumab - Spain’s Almirall - said it expects the launch of the drug in the EU to be delayed by at least six months ... Almirall licensed European rights to the drug in July 2016 and filed for
Latest news
-
Almirall looks to crowdsource new skin health treatments
Almirall looks to crowdsource new skin health treatments. Launches open innovation platform AlmirallShare. ... Spanish pharma company Almirall has set up an online open innovation platform through which it hopes to find skin health solutions.
-
Almirall launches story campaign to raise rosacea awareness
Almirall launches story campaign to raise rosacea awareness. The Red Girl highlights the negative psychological effects of the disease. ... After acquiring Poli Group in 2015, Almirall obtained a dermatology focused R&D structure including its rosacea
-
Finalists revealed for Communiqué Awards 2016
The Burning Issue. by Red Door Unlimited. for Almirall. Creating a faithful following.
-
Pharma needs to 'better articulate' its value to society
Speaking at the Eyeforpharma conference in Barcelona this morning Almirall's CEO Eduardo Sanchiz said: "Let's recognise and be proud that few other industries provide the value to society that
-
Golden night for Saatchi & Saatchi at the PM Society Awards
2015 PM Society Awards winners (Golds). Craft Award for Direct Mail- bmore creative for Almirall.
More from news
Approximately 11 fully matching, plus 67 partially matching documents found.
Latest Intelligence
-
Deal Watch March 2017
12. Symatese. Almirall. Development collaboration. Customised products in aesthetics. 8. AgaImmune.
-
Deal Watch December 2016
510. Nuevolution (Denmark). Almirall (Spain). Research collaboration. RORγt inhibitors for inflammatory skin diseases and psoriatic arthritis. ... $21m plus $80m equity. Biosimilars. Nuevolution. Almirall. $453m. $11.8m. Inhibitors to transcription
-
Deal Watch October 2016
$575m. $198m. 2.9. Respiratory 2014. Almirall. Products pipeline. $2, 100 milestones.
-
Deal Watch July 2016
Celyad. $311m. $12.5m. Almirall. Patagonia. $28m. $3.5m. Petra Pharma. Sprint BioScience. ... Almirall's initial expenditure has been a more modest $3.5m for this earlier stage product.
-
Stronger together
Also speaking at the eyeforpharma conference was Almirall's CEO Eduardo Sanchiz, who noted that, while patient-centricity is often talked about in the industry, “ we have difficulties putting it in
More from intelligence
Approximately 2 fully matching, plus 10 partially matching documents found.
Latest appointments
-
Almirall appoints Peter Guenter as its CEO
Almirall appoints Peter Guenter as its CEO. He joins from Sanofi where he was executive vice president. ... I am convinced he will bring what is needed to develop Almirall to the next level.”.
-
Ron Menezes joins Almirall’s Aqua Pharmaceuticals
Ron Menezes joins Almirall’ s Aqua Pharmaceuticals. He joins the US dermatology group as its president and general manager. ... Sanchiz added: “Almirall continues to consider Aqua as a very important platform in the US market to support existing and
-
ThermiGen appoints Vladimir Paul-Blanc as president
ThermiGen appoints Vladimir Paul-Blanc as president. He will also serve as the Almirall-owned firm's general manager. ... He said: “I couldn’t be more excitied to join Almirall and work with the Thermi organisation.
-
Caldan Therapeutics bolsters senior team
Most recently, Dr Connolly served as scientific leader with Almirall, based in Barcelona, Spain.
-
Red Door promotes Matt Lowe and Katy Pogson
Aldous joined Red Door in 2011 from Red Health as a senior account manager and currently leads accounts for Sanofi, MSD, Baxter, Almirall and Astellas.
More from appointments
Approximately 5 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Solaris Health
Abbvie. Aimmune. Almirall. Ascensia. BD. Bio-Medical Research. Desitin. Ferring. Flexyfoot. Gedeon Richter.
-
HAVAS LYNX
AbbVie. Alexion. Almirall. Astellas. AstraZeneca. Bayer. Eisai. Genzyme. Janssen. Kowa. Lilly.
-
HAVAS LYNX
AbbVie. Alexion. Almirall. Astellas. AstraZeneca. Bayer. Eisai. Genzyme. Janssen. Kowa. Lilly.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Featured jobs
- Science Writer – Healthcare Advertising
-
Salary TBC
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Senior Account Director or Business Unit Director, Healthcare Ad...
-
C£60, 000 – £70, 000 benefits
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
Competitive salary
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Medical Writer, Healthcare Advertising
-
£35 - £45, 000 benefits
- Medical Writer - Medical Communications
-
£30, 000 - £40, 000 according to skills and experience plus benefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
Subscribe to our email news alerts
PMHub
Life Healthcare Communications
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...
Latest intelligence
- ‘How is your day?’
- The initiative that shows how plasma protein therapies improve lives...
- Advancing women in healthcare
- Fostering the next generation of leaders...
- The Challenges Of UX In Healthcare: Technology To Change Lives
- Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
Quick links
Infographics
